Company: NOTV
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001628280-25-023370
Chunk: 174

Company: Inotiv, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 8
Chunk 174
---
 cash inflows of $3,964 related to the proceeds from the sale of property and equipment, which primarily related to the sale of various sites in connection with our site optimization strategy.

Net cash provided by financing activities of $25,493 in the six months ended March 31, 2025 primarily included net proceeds from the issuance of common shares of $27,524 and borrowings on the revolving credit facility of $20,000, partially offset by payments on the revolving credit facility of $20,000.

Net cash used in financing activities of $4,094 in the six months ended March 31, 2024 included other net financing payments of $2,712 and principal payments of $1,382 on the senior term notes and delayed draw term loans.

Capital Resources

42

Long-term debt as of March 31, 2025 and September 30, 2024 is detailed in the table below. 

March 31, 2025September 30, 2024Seller Note – Bolder BioPath (Related party)$263 $376 Seller Note – Preclinical Research Services— 464 Seller Payable - Orient BioResource Center3,235 3,700 Seller Note – Histion (Related party)12 84 Second Lien Notes20,485 17,846 Convertible Senior Notes113,124 109,979 Term Loan Facility, DDTL and Incremental Term Loans271,864 272,840 Total debt before unamortized debt issuance costs$408,983 $405,289 Less: Debt issuance costs not amortized(9,443)(11,950)Total debt, net of unamortized debt issuance costs$399,540 $393,339 Less: Current portion(7,146)(3,538)Total Long-term debt$392,394 $389,801 

Revolving Credit Facility

As of March 31, 2025 and September 30, 2024, the Company had no outstanding balance on the revolving credit facility. Refer to the condensed consolidated statements of cash flows for information related to borrowings and payments on the revolving credit facility during the six months ended March 31, 2025. 

Term Loan Facility, DDTL and Incremental Term Loans

Below are the weighted-average effective interest rates for the loans available under the Credit Agreement:

Three Months EndedMarch 31,Six Months EndedMarch 31,2025202420252024Effective